White label ELPA - ClinicalTrials.eu

Study on Stopping Nivolumab or Pembrolizumab in Advanced Melanoma Patients After Achieving a Response

Recruiting

3 1 1 1
Investigated Diseases:
- Malignant melanoma
Investigated Drugs:
- Nivolumab
- Pembrolizumab
Study on Botulinum Toxin Type A for Preventing Shoulder Deformity in Infants with Brachial Plexus Palsy

Recruiting

3 1 1
Investigated Drugs:
- Botulinum Toxin Type A
- Sodium Chloride
Study on the Long-Term Safety of Belimumab for Adults with Systemic Sclerosis-Related Lung Disease

Recruiting

3 1 1 1
Investigated Drugs:
- Belimumab
+2
Study on the Effectiveness of Early PSMA-PET Scans with Gozetotide in Patients with Metastatic Renal Cancer Undergoing Standard Immunotherapy

Recruiting

2 1 1 1
Investigated Drugs:
- Gozetotide
Study on the Effects of Tumor Removal in Patients with Metastatic Kidney Cancer Treated with Nivolumab and Ipilimumab Combination

Recruiting

3 1 1 1
Investigated Diseases:
- Metastatic renal cell carcinoma
Investigated Drugs:
Study Comparing Intrathecal Morphine and TAP Block with Ropivacaine and Clonidine for Pain Relief in Patients Undergoing Elective Cesarean Section

Recruiting

3 1 1 1
Investigated Diseases:
- Caesarean section
Investigated Drugs:
- Clonidine Hydrochloride
- Ropivacaine Hydrochloride
Study on the Effects of Cholecalciferol and Glycerol on Inflammation in Obese Elderly Patients with Vitamin D Deficiency

Recruiting

3 1 1
Investigated Diseases:
- Obesity
Investigated Drugs:
- Glycerol
- Colecalciferol
Study on the Safety of Rotigotine for Patients with Autosomal Dominant Polycystic Kidney Disease

Recruiting

2 1 1 1
Investigated Diseases:
- Congenital cystic kidney disease
Investigated Drugs:
- Rotigotine
Study of Dostarlimab for Patients with Untreated Stage III Resectable Colon Cancer

Recruiting

2 1 1 1
Investigated Diseases:
- Colon cancer
Investigated Drugs:
- Dostarlimab
Study of PF-06821497 and Enzalutamide for Men with Advanced Prostate Cancer Resistant to Hormone Therapy

Recruiting

3 1 1
Investigated Diseases:
- Hormone-refractory prostate cancer
- Prostate cancer metastatic
Investigated Drugs:
- 5,8-Dichloro-2-[(4-Methoxy-6-Methyl-2-Oxo-1,2-Dihydropyridin-3-Yl)Methyl]-7-[(R)-Methoxy(Oxetan-3-Yl)Methyl]-3,4-Dihydroisoquinolin-1(2H)-One
- Enzalutamide
+8

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies